Skip to main content

UBS Group AG

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1610520 ZURICH, V8

Position in HRTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,288,740
-$539,966 QoQ
Shares Held
2,997,073
+31.1% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 161 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. HRTX ranks #249 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HRTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,288,740 2,997,073
2026-03-31 $1,828,706 2,285,883
2025-12-31 $2,719,168 2,091,669
2025-09-30 $3,696,940 2,934,081
2025-06-30 $6,592,876 3,184,965
2025-03-31 $349,224 158,739
2024-12-31 $243,997 159,476
2024-09-30 $169,653 85,253
2024-06-30 $583,775 166,793
2024-03-31 $308,561 111,394
2023-12-31 $206,508 121,476
2023-09-30 $64,957 63,066
2023-06-30 $80,081 69,037
2023-03-31 $84,208 55,768
2022-12-31 $92,232 36,893
2022-09-30 $370,882 87,887
2022-06-30 $22,490 8,061
2022-03-31 $1,339,165 234,120
2021-12-31 $2,914,815 319,257
2021-09-30 $2,652,272 248,108
2021-06-30 $125,944 8,115
2021-03-31 $2,397,522 147,904
2020-12-31 $2,782,796 131,450
2020-09-30 $1,357,274 91,584
2020-06-30 $1,682,515 114,379
2020-03-31 $1,471,256 125,320